As such, measurement of CSF orexin-A concentrations could be considered in the diagnostic workup of patients with cognitive impairment and dementia, considering the possibility of correlating CSF levels of this neuropeptide with neuropsychiatric symptoms, with particular attention to sleep and the sleep-wake cycle. The gene discussed is HCRT; the disease is dementia.